TRANSFORMED SMALL CELL LUNG CANCER
Clinical trials for TRANSFORMED SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for TRANSFORMED SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare, aggressive lung cancer: experimental drug trial opens
Disease control Not yet recruitingThis study is testing whether a new medicine called PF-08634404 works better when given with standard chemotherapy for a rare, aggressive form of lung cancer called transformed small cell lung cancer. The trial will enroll 40 adults who haven't received treatment for this specifi…
Matched conditions: TRANSFORMED SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for rare, Tough-to-Treat lung cancer
Disease control Not yet recruitingThis study is testing the safety and effectiveness of combining two drugs, lurbinectedin and osimertinib, for a rare and aggressive type of lung cancer called transformed small cell lung cancer. It will involve about 16 adults whose cancer started as one type and changed into thi…
Matched conditions: TRANSFORMED SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Misty Shields • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC